Przegląd Dermatologiczny

Full text

2/2026 vol. 113
Case report

Halo Nevi Phenomenon Revealing Melanoma

  1. Department of Dermatology and Venereology, Medical University of Bialystok, Poland

Dermatol Rev/Przegl Dermatol 2026, 113, 89–91

Data publikacji online: 2026/07/31
Article file
Halo Nevi Phenomenon.pdf
Confronting perimenopausal women’s knowledge of coronary heart disease with their health behaviours. Controversial role of hormone replacement therapy in the protection of coronary heart disease
  1. Naveh H.P., Rao U.N., Butterfield L.H.: Melanoma-associated leukoderma – immunology in black and white? Pigment Cell Melanoma Res 2013, 26, 796-804.
  2. Nedelcu R., Dobre A., Brinzea A., Hulea I., Andrei R., Zurac S.: Current challenges in deciphering Sutton nevi – literature review and personal experience. J Pers Med 2021, 11, 904.
  3. Weyant G.W., Chung C.G., Helm K.F.: Halo nevus: review of the literature and clinicopathologic findings. Int J Dermatol 2015, 54, e433-e435.
  4. Kolm I., Di Stefani A., Hofmann-Wellenhof R., Fink-Puches R., Wolf I.H., Richtig E.: Dermoscopy patterns of halo nevi. Arch Dermatol 2006, 142, 1627-32.
  5. Lorentzen H.F.: Eruptive halo naevi: a possible indicator of malignant disease in a case series of post-adolescent patients. Acta Derm Venereol 2020, 100, adv00228.
  6. Rubegni P., Nami N., Risulo M., Tataranno D., Fimiani M.: Melanoma with halo. Clin Exp Dermatol 2009, 34, 749-750.
  7. Ohsie S.J., Sarantopoulos G.P., Cochran A.J., Binder S.W.: Immunohistochemical characteristics of melanoma. J Cutan Pathol 2008, 35, 433-444.
  8. Cazzato G., Mangialardi K., Falcicchio G., Colagrande A., Ingravallo G., Arezzo F.: Preferentially expressed antigen in melanoma (PRAME) and human malignant melanoma: a retrospective study. Genes 2022, 13, 545.
Copyright: © 2026 Polish Dermatological Association. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Share
without publication fees
without publication fees